FORM FDA 1571. Investigational New Drug Application (IND)-2025

Get Form
fda form 1571 Preview on Page 1

Here's how it works

01. Edit your fda form 1571 online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send fda 1571 via email, link, or fax. You can also download it, export it or print it out.

How to change FORM FDA 1571. Investigational New Drug Application (IND) online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

With DocHub, making adjustments to your paperwork takes only some simple clicks. Make these fast steps to change the PDF FORM FDA 1571. Investigational New Drug Application (IND) online for free:

  1. Register and log in to your account. Sign in to the editor with your credentials or click on Create free account to evaluate the tool’s functionality.
  2. Add the FORM FDA 1571. Investigational New Drug Application (IND) for editing. Click the New Document option above, then drag and drop the sample to the upload area, import it from the cloud, or via a link.
  3. Alter your document. Make any adjustments required: add text and images to your FORM FDA 1571. Investigational New Drug Application (IND), underline important details, erase parts of content and substitute them with new ones, and insert icons, checkmarks, and fields for filling out.
  4. Finish redacting the template. Save the modified document on your device, export it to the cloud, print it right from the editor, or share it with all the people involved.

Our editor is very easy to use and efficient. Try it now!

See more FORM FDA 1571. Investigational New Drug Application (IND) versions

We've got more versions of the FORM FDA 1571. Investigational New Drug Application (IND) form. Select the right FORM FDA 1571. Investigational New Drug Application (IND) version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2019 4.8 Satisfied (55 Votes)
2018 4.1 Satisfied (69 Votes)
2006 4.4 Satisfied (172 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The purpose of the Form FDA 1571 is to: obtain agreement from the sponsor (or sponsor-investigator) to conduct research ing to all appropriate FDA regulations; and. serve as a cover sheet for all submissions to the FDA on behalf of a particular IND.
The cover letter should be on departmental letterhead. Title the cover letter: Initial Investigational New Drug Application Brief explanation of the investigation (i.e., use the study title) Disease or condition being studied.
The Form FDA 1571 is used to obtain agreement from a sponsor or sponsor-investigator to conduct research in adherence to all appropriate FDA regulations. It also serves as a cover sheet and is completed for every submission sent to the FDA on behalf of a specific IND.
Filing an IND requires completion of 3 sets of forms: 1 detailing the study (FDA Form 1571), 1 providing information about the investigator and study site (FDA Form 1572), and 1 certifying that the study is registered in the national database of clinical trials (FDA Form 3674).
It is used in a clinical trial to investigate its safety and efficacy. The term also includes biological products that are used in vitro for diagnostic purposes. An IND application is a request for authorization from the FDA to administer an investigational drug or biological product to humans.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Form FDA 3500 may be used by health professionals or consumers for VOLUNTARY reporting of adverse events, product use/medication errors, product quality problems, and therapeutic failures for: Prescription and over-the-counter medicines including those administered in a hospital or outpatient infusion centers.
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.

1571 fda